Endothelial injury is one of the risk factors for the progression of vascular calcification in patients receiving maintenance dialysis
- PMID: 39865575
- PMCID: PMC11774155
- DOI: 10.1080/0886022X.2025.2456690
Endothelial injury is one of the risk factors for the progression of vascular calcification in patients receiving maintenance dialysis
Abstract
Background: Vascular calcification is common and progressive in patients with chronic kidney disease. However, the risk factors associated with the progression of vascular calcification in patients receiving maintenance dialysis have not been fully elucidated. Here, we aimed to evaluate vascular calcification and identify the factors associated with its progression in patients receiving maintenance hemodialysis.
Methods: This is a prospective longitudinal study that included 374 patients receiving maintenance hemodialysis. The participants received assessments of coronary artery calcification (CAC) and abdominal aortic calcification (AAC), as measured by computed tomography. After the baseline investigation, a 2 years follow-up was performed. We also detected the markers of endothelial injury [E-selectin and soluble intercellular adhesion molecule-1 (sICAM-1)]. Finally, the risk factors affecting the CAC and AAC progression were examined by multivariate logistic regression analysis.
Results: Among 374 patients, the median [interquartile range (IQR)] age was 54.0 (40.0-62.0) years; 59.9% of patients were male. The median (IQR) follow-up time was 1.9 (1.8-2.0) years for all patients. By the end of 2-year follow-up, progression of vascular calcification (including CAC and AAC) was observed in 58.0% of patients. Further, compared with the patients without progression of vascular calcification, the endothelial injury (including E-selectin and sICAM-1) of patients with progression of vascular calcification was markedly enhanced. Moreover, after adjustment for the confounders, endothelial injury was a risk factor for the progression of vascular calcification.
Conclusion: The present study indicated that endothelial injury is one of the risk factors for the progression of vascular calcification in patients receiving maintenance hemodialysis.
Keywords: Endothelial injury; maintenance dialysis; risk factor; vascular calcification.
Conflict of interest statement
The authors have no conflicting interest to disclose.
Figures
Similar articles
-
Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.Am J Nephrol. 2018;48(5):369-377. doi: 10.1159/000494665. Epub 2018 Nov 13. Am J Nephrol. 2018. PMID: 30423550 Free PMC article.
-
Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis.JAMA Netw Open. 2023 May 1;6(5):e2310909. doi: 10.1001/jamanetworkopen.2023.10909. JAMA Netw Open. 2023. PMID: 37126347 Free PMC article.
-
Elevated concentrations of cardiac troponin T are associated with thoracic aortic calcification in non-dialysis chronic kidney disease patients of stage G3 to G5.Ren Fail. 2025 Dec;47(1):2440512. doi: 10.1080/0886022X.2024.2440512. Epub 2024 Dec 18. Ren Fail. 2025. PMID: 39694530 Free PMC article.
-
Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.PLoS One. 2018 Jul 3;13(7):e0199160. doi: 10.1371/journal.pone.0199160. eCollection 2018. PLoS One. 2018. PMID: 29969455 Free PMC article.
-
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?Osteoporos Int. 2015 Aug;26(8):2165-74. doi: 10.1007/s00198-015-3127-9. Epub 2015 Apr 25. Osteoporos Int. 2015. PMID: 25910747
Cited by
-
Construction and validation of a risk prediction model for extensive abdominal aortic calcification in hypertensive patients aged 40 and above: a cross-sectional study based on the 2013-2014 NHANES database.BMC Cardiovasc Disord. 2025 Jul 4;25(1):462. doi: 10.1186/s12872-025-04912-4. BMC Cardiovasc Disord. 2025. PMID: 40610961 Free PMC article.
-
Isowighteone attenuates vascular calcification by targeting HSP90AA1-mediated PI3K-Akt pathway and suppressing osteogenic gene expression.Front Bioeng Biotechnol. 2025 Aug 20;13:1636883. doi: 10.3389/fbioe.2025.1636883. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40909222 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical